The Global Landscape of Stem Cell Clinical Trials

• Appelbaum FR . Hematopoietic-cell transplantation at 50. N. Engl. J. Med.357(15) , 1472–1475 (2007).
   PubMed Web of Science ®Google Scholar
• Thomas ED , LochteHL Jr, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N. Engl. J. Med.257(11) , 491–496 (1957).
   PubMed Web of Science ®Google Scholar
• Bubela T , LiMD, HafezM, BieberM, AtkinsH. Is belief larger than fact: expectations, optimism and reality for translational stem cell research. BMC Med.10 , 133 (2012).
   PubMed Web of Science ®Google Scholar
• Regenberg AC , HutchinsonLA, SchankerB, MathewsDJ. Medicine on the fringe: stem cell-based interventions in advance of evidence. Stem Cells27(9) , 2312–2319 (2009).
   PubMed Web of Science ®Google Scholar
• Lau D , OgboguU, TaylorB, StafinskiT, MenonD, CaulfieldT. Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell3(6) , 591–594 (2008).
   PubMed Web of Science ®Google Scholar
• Daley GQ . The promise and perils of stem cell therapeutics. Cell Stem Cell10(6) , 740–749 (2012).
   PubMed Web of Science ®Google Scholar
• Dominici M , Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy8(4) , 315–317 (2006).
   PubMed Web of Science ®Google Scholar
• Cyranoski D . Stem cells cruise to clinic. Nature494(7438) , 413 (2013).
   PubMed Web of Science ®Google Scholar
• Mathews DJ , Cook-DeeganR, BubelaT. Patents and misplaced angst: lessons for translational stem cell research from genomics. Cell Stem Cell12(5) , 508–512 (2013).
   PubMed Web of Science ®Google Scholar
• Pera MF . The dark side of induced pluripotency. Nature471(7336) , 46–47 (2011).
   PubMed Web of Science ®Google Scholar
• Zwaka TP . Stem cells: troublesome memories. Nature467(7313) , 280–281 (2010).
   PubMed Web of Science ®Google Scholar
• Hyun I , LindvallO, Ahrlund-RichterL et al. New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell 3(6) , 607–609 (2008).
   PubMed Web of Science ®Google Scholar
• Mason C , BrindleyDA, Culme-SeymourEJ, DavieNL. Cell therapy industry: billion dollar global business with unlimited potential. Regen. Med.6(3) , 265–272 (2011).
   PubMed Web of Science ®Google Scholar
• Rao MS . Funding translational work in cell-based therapy. Cell Stem Cell9(1) , 7–10 (2011).
   PubMed Web of Science ®Google Scholar
• Trounson A , ThakarRG, LomaxG, GibbonsD. Clinical trials for stem cell therapies. BMC Med.9 , 52 (2011).
   PubMed Web of Science ®Google Scholar
• Gratwohl A , BaldomeroH, FrauendorferK et al. Hematopoietic stem cell transplantation: a global perspective. JAMA 303(16) , 1617–1624 (2010).
   PubMed Web of Science ®Google Scholar
• Weiss DJ , BersoncelloI, BorokZ, KimC et al. Stem cells and cell therapies in lung biology and lung diseases. Proc. Am. Thorac. Soc. 8(3) , 223–272 (2011).
   PubMedGoogle Scholar
• Dalal J , GandyK, DomenJ. Role of mesenchymal stem cell therapy in Crohn‘s disease. Pediatr. Res.71(4 Pt 2) , 445–451 (2012).
   PubMed Web of Science ®Google Scholar
• Barcala Tabarrozzi AE , CastroCN, DeweyRA, SogayarMC, LabriolaL, PeroneMJ. Cell-based interventions to halt autoimmunity in Type 1 diabetes mellitus. Clin. Exp. Immunol.171(2) , 135–146 (2013).
   PubMed Web of Science ®Google Scholar
• Tyndall A . Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases. Pediatr. Res.71(4 Pt 2) , 433–438 (2012).
   PubMed Web of Science ®Google Scholar
• Williams AR , HareJM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ. Res.109(8) , 923–940 (2011).
   PubMed Web of Science ®Google Scholar
• Rosenweig A . Cardiac regeneration. Science338(6114) , 1549–1550 (2012).
   PubMed Web of Science ®Google Scholar
• Ptaszek LM , MansourM, RuskinJN, ChienKR. Towards regenerative therapy for cardiac disease. Lancet379(9819) , 933–942 (2012).
   PubMed Web of Science ®Google Scholar
• Mummery CL , LeeRT. Is heart regeneration on the right track? Nat. Med.19(4) , 412–413 (2013).
   PubMed Web of Science ®Google Scholar
• Lawall H , BramlageP, AmannB. Treatment of peripheral arterial disease using stem and progenitor cell therapy. J. Vasc. Surg.53(2) , 445–453 (2011).
   PubMed Web of Science ®Google Scholar
• Bednar MM , PerryA. Neurorestoration therapeutics for neurodegenerative and psychiatric disease. Neurol. Res.34(2) , 129–142 (2012).
   PubMed Web of Science ®Google Scholar
• Aboody K , CapelaA, NiaziN, SternJH, TempleS. Translating stem cell studies to the clinic for cns repair: current state of the art and the need for a Rosetta stone. Neuron70(4) , 597–613 (2011).
   PubMed Web of Science ®Google Scholar
• Baker M . Stem-cell pioneer bows out. Nature479(7274) , 459 (2011).
   PubMedGoogle Scholar
• Schwartz SD , HubschmanJP, HeilwellG et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379(9817) , 713–720 (2012).
   PubMed Web of Science ®Google Scholar
• Ahmad S . Concise review: limbal stem cell deficiency, dysfunction, and distress. Stem Cells Transl. Med.1(2) , 110–115 (2012).
   PubMed Web of Science ®Google Scholar
• Osei-Bempong C , FigueiredoFC, LakoM. The limbal epithelium of the eye – a review of limbal stem cell biology, disease and treatment. BioEssays35(3) , 211–219 (2013).
   PubMed Web of Science ®Google Scholar
• Tibbetts MD , SamuelMA, ChangTS, HoAC. Stem cell therapy for retinal disease. Curr. Opin. Ophthalmol.23(3) , 226–234 (2012).
   PubMed Web of Science ®Google Scholar
• Martin PA , CoveneyC, KraftA, BrownN, BathP. Commercial development of stem cell technology: lessons from the past, strategies for the future. Regen. Med.1(6) , 801–807 (2006).
   PubMed Web of Science ®Google Scholar
• Reed W , NogaSJ, GeeAP et al. Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies. Transfusion 49(4) , 786–796 (2009).
   PubMed Web of Science ®Google Scholar
• von Tigerstom B . The Food and Drug Administration, regenerative sciences, and the regulation of autologous stem cell therapies. Food Drug Law J.66(4) , 479–506 (2011).
   PubMed Web of Science ®Google Scholar

▪ Websites

• NIH. ClinicalTrials.gov. http://clinicaltrials.gov (Accessed 12October2013)
   Google Scholar
• Alliance for Regenerative Medicine. ARM 2013 Regenerative Medicine Annual Report. http://alliancerm.org/news/download-must-have-industry-report (Accessed 12October2013)
   Google Scholar
• WHO. International Clinical Trials Registry Platform. http://apps.who.int/trialsearch (Accessed 12October2013)
   Google Scholar
• Bureau Van Dijk. Orbis. www.bvdinfo.com (Accessed 12October2013)
   Google Scholar
• Rattue P. Prochymal – First Stem Cell Drug Approved. Medical News Today (2012). www.medicalnewstoday.com/articles/245704.php (Accessed 12October2013)
   Google Scholar
• Osiris Therapeutics, I (2013). Therapeutics. Prochymal. www.osiris.com/therapeutics.php (Accessed 12October2013).
   Google Scholar